13F Holdings
中文EN

BON Bon Natural Life Ltd Annual reports only

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1816815 · Fiscal year ends 09/30

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-21.7%
TTM net income YoY-601.0%
TTM EPS YoY-117.4%
Revenue 3-yr CAGR-14.5%
Net income 3-yr CAGR—

Margins

Gross margin20.8%
Operating margin-8.7%
Net margin-10.7%
FCF margin0.7%
EBITDA margin-2.9%

Returns

ROE-3.9%
ROA-2.7%
ROIC (approx.)-2.6%
Asset turnover0.25x

Leverage & solvency

Liabilities / assets31.9%
Debt / equity0.03x
Current ratio1.74x
Interest coverage-4.43x

Cash quality & payout

Operating cash flow / net income-0.07x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30FY20212021-09-30
Income statement
Revenue$18.67M$23.84M$29.52M$29.91M$25.49M
Cost of revenue$14.79M$16.73M$20.68M$20.48M$18.38M
Gross profit$3.88M$7.11M$8.84M$9.42M$7.11M
R&D expense$754,193$1.62M$298,469$424,558$249,050
SG&A expense$4.31M$3.35M$2.31M$2.18M$1.32M
Operating income-$1.62M$1.87M$5.94M$6.60M$5.40M
Interest expense$366,180$303,325$238,224$446,884$417,266
Pretax income-$1.71M$715,939$5.57M$7.57M$5.43M
Income tax$339,414$351,179$1.00M$1.27M$820,931
Net income-$1.99M$398,172$4.60M$6.24M$4.59M
EBITDA-$535,580$2.98M$6.89M$6.82M$5.63M
EPS (basic)-0.724.17125.727.470.69
EPS (diluted)-0.724.14124.927.430.68
Weighted avg. shares (diluted)2.76M96,11436,792839,6066.71M
Balance sheet
Cash & equivalents$6.27M$658,610$112,751$840,861$1.90M
Short-term investments——$65—$1.70M
Receivables$11.01M$11.78M$4.60M$6.78M$6.15M
Inventory$3.31M$1.57M$987,287$1.72M$1.60M
Current assets$45.76M$39.79M$24.18M$14.72M$16.55M
PP&E, net$18.16M$15.01M$15.48M$21.62M$19.23M
Intangibles$6.42M$776,995$766,350$366,167$411,056
Total assets$85.19M$61.77M$46.56M$37.26M$36.41M
Current liabilities$26.31M$16.45M$9.61M$6.65M$7.53M
Short-term debt$1.08M$461,765$419,610$2.14M$448,005
Long-term debt$842,815$970,061$871,368$189,813$2.17M
Total debt$1.92M$1.43M$1.29M$2.33M$2.62M
Total liabilities$27.19M$17.42M$10.57M$7.16M$9.88M
Shareholders' equity$57.55M$43.91M$35.48M$29.56M$26.01M
Net debt-$4.34M$773,216$1.18M$1.48M$717,670
Shares outstanding—3.97M1.17M8.40M8.33M
Cash flow statement
Operating cash flow$141,115-$7.72M-$616,904-$187,121$4.05M
Capital expenditure$6,827$7,047$61,906$27,695$51,878
Free cash flow$134,288-$7.73M-$678,810-$214,816$4.00M
Investing cash flow-$10.00M-$15,727-$1.19M-$3.06M-$7.44M
Financing cash flow$15.45M$8.76M$1.16M$2.26M$5.35M
Depreciation & amortization$1.09M$1.11M$949,550$215,630$228,547
Stock-based compensation$1.39M$1.32M$349,396$170,883$422,221

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.